Validation of the association between circulating protein levels and gallbladder cancer risk in Europeans

Validation of the association between circulating protein levels and gallbladder cancer risk in Europeans - ProtGBC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031984

Enrollment

Registered

2023-06-06

Start date

2016-07-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C23

Interventions

Group 1: Prospective cases diagnosed with gallbladder cancer (GBC, ICD 10: C23 – malignant neoplasm of gallbladder). Individuals of European ancestry who developed GBC after blood sample collection. P

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Selected controls were cancer-free

Exclusion criteria

Exclusion criteria: cancer diagnosis other than GBC

Design outcomes

Primary

Measure	Time frame
ICD 10: C23 – malignant neoplasm of gallbladder diagnosed no more than 20 years after blood collection.	—

Countries

Denmark, Estonia, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom

Contacts

Public ContactJusto Lorenzo Bermejo

Universität Heidelberg

lorenzo@imbi.uni-heidelberg.de+4906221 564180

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026